Current Opinion in Organ Transplantation was launched in 1996. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of organ transplantation is divided into 18 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Herman Waldmann, FRS is Emeritus Professor of Pathology and former Head of the Sir William Dunn School of Pathology at the University of Oxford, UK. An immunologist, he is best known for his work on therapeutic monoclonal antibodies, particularly Campath-1, now licensed as Alemtuzumab/Lemtrada for the treatment of Multiple Sclerosis.
His mechanistic studies of tolerance uncovered a role for regulatory T-cells in infectious tolerance which was published in a seminal paper in Science in 1993. The strategies emerging from his laboratory since that time have been based on the use of therapeutic antibodies to enhance regulation over conventional T-cell immunity.
Uwe Heemann was trained at the University of Essen, Germany, and the Harvard Medical School, USA, before taking over as head of the Department of Nephrology at the Technical University in Munich, Germany.
He has received various honours, research awards of the Transplant Society, the European Dialysis and Transplantation Association as well as the Silver Plate Awards of the Hungarian Society of Nephrology and the Hans-U. Zollinger Medal of the German Society of Nephrology among them.
He has been President of the German Transplant Academy as well as the German Society of Transplantation and is currently the Chairman of the Eurotransplant kidney advisory committee as well as the Stiftung Lebendspende.
His primary focus of research is on the field of chronic rejection and ischemia/reperfusion. He has published more than 300 articles and various book chapters.
RenÉ J. Duquesnoy
RenÉ Duquesnoy is a transplant immunologist and Professor Emeritus at the University of Pittsburgh Medical Center, USA. He has previously directed the histocompatibility testing services for the transplant programs at UPMC. His research interests are the structural basis of HLA compatibility, the antibody responses to HLA and MICA epitopes and the determination of HLA mismatch acceptability and permissibility for transplantation and platelet transfusion.